Aktie 4BDX BECTON, DICKINSON AND COMPANY
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Becton, Dickinson and Company Borsa Italiana

Aktien

4BDX

US0758871091

4BDX

Realtime-Estimate Tradegate
Andere Börsenplätze
 16:39:23 17.07.2024 		% 5 Tage % 1. Jan.
213,2 EUR +1,69 % Intraday Chart für Becton, Dickinson and Company +0,58 % -4,94 %
10.07. US FDA meldet Mangel an Blutröhrchen von Becton Dickinson RE
10.07. Becton, Dickinson übertrifft Emissionsreduktionsziele für 2023 MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Becton Dickinson and : Material Agreement Form 8 K
BD Statement on Supplier Issue Impacting BD BACTEC Blood Culture Vials
Health Care Up in Anticipation of Deal Activity -- Health Care Roundup
FDA Reports Supply Interruptions for Becton Dickinson BD BACTEC Culture Media Bottles
US FDA flags shortage of Becton Dickinson's blood test tubes
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials
Becton, Dickinson Says it Exceeded 2023 Emissions Reduction Targets
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023
BD to Announce Financial Results for its Third Quarter of Fiscal 2024
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
Becton Dickinson and : BD Issues Annual Product Security Report, Highlighting Transparency and Collaboration
Sector Update: Health Care Stocks Steady Premarket Monday
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 857675 Aktie
  4. 4BDX Aktie
  5. Nachrichten Becton, Dickinson and Company
  6. Andere Sprachen